Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Eric A. Mellon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9892-8402; OpenAlex author ID A5071445561. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
76
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 3 papers · 2017: 2 papers · 2018: 2 papers · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 15

  1. Predictive Value of Delta-Radiomics Texture Features in 0.35 Tesla Magnetic Resonance Setup Images Acquired During Stereotactic Ablative Radiotherapy of Pancre… Co-author DOI 10.3389/fonc.2022.807725↗
  2. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study. Co-author DOI 10.1002/mp.14200↗
  3. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Co-author DOI 10.1002/cam4.2100↗
  4. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer. Last author DOI 10.1016/j.prro.2018.08.010↗
  5. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. Co-author DOI 10.1093/jnci/djz073↗
  6. Dosimetric analysis of stereotactic body radiation therapy for pancreatic cancer using MR-guided Tri-60Co unit, MR-guided LINAC, and conventional LINAC-based p… Co-author DOI 10.1016/j.prro.2018.02.010↗
  7. Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy. First author DOI 10.21037/jgo.2017.09.13↗
  8. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy… Co-author DOI 10.1080/0284186x.2016.1256497↗
  9. Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy. First author DOI 10.21037/jgo.2017.08.05↗
  10. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Co-author DOI 10.1016/s1470-2045(16)00172-8↗
  11. Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy co… Co-author DOI 10.21037/jgo.2016.03.15↗
  12. Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. Co-author DOI 10.3978/j.issn.2078-6891.2015.075↗
  13. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarc… Co-author DOI 10.3109/0284186x.2015.1004367↗
  14. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy. Co-author DOI 10.1002/cncr.28543↗
  15. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Co-author DOI 10.1016/j.ijrobp.2013.02.022↗

Closest collaborators

The 25 strongest of 76 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lorraine Portelance · 5 shared papers, 2018–2022 · strength 0.55
  2. Sarah E. Hoffe · 8 shared papers, 2013–2018 · strength 0.46
  3. Mokenge Peter Malafa · 8 shared papers, 2013–2018 · strength 0.46
  4. Pamela Joy Hodul · 8 shared papers, 2013–2018 · strength 0.46
  5. Jessica M. Frakes · 7 shared papers, 2015–2019 · strength 0.44
  6. Ravi Shridhar · 8 shared papers, 2013–2017 · strength 0.42
  7. Benjamin Oren Spieler · 3 shared papers, 2019–2022 · strength 0.39
  8. Gregory M. Springett · 7 shared papers, 2013–2017 · strength 0.38
  9. Nesrin Dogan · 3 shared papers, 2018–2022 · strength 0.36
  10. William H. Jin · 3 shared papers, 2017–2022 · strength 0.32
  11. Garrett Simpson · 2 shared papers, 2020–2022 · strength 0.28
  12. Michael David Chuong · 4 shared papers, 2013–2016 · strength 0.20
  13. Tobin Joel Crill Strom · 3 shared papers, 2015–2017 · strength 0.18
  14. Kenneth Lee Meredith · 3 shared papers, 2013–2017 · strength 0.14
  15. Parag Jitendra Parikh · 2 shared papers, 2019 · strength 0.14
  16. Barbara Ann Centeno · 2 shared papers, 2016–2017 · strength 0.12
  17. Fei Yang · 1 shared paper, 2020 · strength 0.12
  18. Nancy El-Bared · 1 shared paper, 2019 · strength 0.11
  19. Sing Yu Moorcraft · 2 shared papers, 2016–2019 · strength 0.10
  20. Mustafa Suker · 2 shared papers, 2016–2019 · strength 0.10
  21. Ian Chau · 2 shared papers, 2016–2019 · strength 0.10
  22. Bas Groot Koerkamp · 2 shared papers, 2016–2019 · strength 0.10
  23. Peter J. Hosein · 2 shared papers, 2016–2019 · strength 0.10
  24. Casper H.J. van Eijck · 2 shared papers, 2016–2019 · strength 0.10
  25. Jill Lacy · 2 shared papers, 2016–2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.